Day 3 (2021)
Over the past 50 years, our mission at the National Headache Foundation has been to further awareness of headache and migraine as legitimate neurobiological diseases. Much has changed during this time. With aid from advanced technology and clinical innovation, there are more treatment options than ever before. However, we understand that these diseases are still largely misunderstood and that finding the right treatment options for you requires insight.
Impel NeuroPharma, Inc. is a late-stage biopharmaceutical company focused on developing transformative therapies that unlock the full potential of therapeutic molecules for people living with CNS disorders with high unmet medical needs. Impel NeuroPharma is the first company to investigate targeting the upper nasal space with optimized therapeutic molecules and formulations for treating CNS diseases.
The Summit Co-Host and Producer, Paula is an alumni speaker who is a former business executive with chronic migraine, now thriving as a leading health advocate and editor.
Today's Interviews
Preventing Attacks Before They Happen
Jan Lewis Brandes, MD
Assistant Clinical Professor of Neurology
Vanderbilt University
How Weight Affects Migraine Disease
Dale Bond, PhD
Professor of Psychiatry & Human Behavior (Research)
The Miriam Hospital and Brown Alpert Medical School Weight Control and Diabetes Research Center
Light Sensitivity and Therapy for Migraine
Deborah Friedman, MD, MPH, FAAN, FAHS
Neuro-Ophthalmologist & Headache Specialist
Yellow Rose Headache & Neuro-Ophthamology
How to Manage Weather Triggers
Jan Hoffmann, MD, PhD
Clinical Senior Lecturer & Honorary Consultant in Neurology
King's College London
[Sponsored] Is the Gut-Brain Connection at the Heart of Oral Migraine Treatment Failure?
Nada Hindiyeh, MD
Clinical Assistant Professor & Director of Clinical Research in Headache Medicine
Stanford University
Purchase full access to the entire 2024 Summit. Includes:
- All expert interviews with separate audio (MP3) files & transcripts
- Lifetime on-demand access with no annual fee to 2024 Summit
- Interview Summaries
- Treatment Guidelines
- And much more!
